Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-10-038106)

Filing Details

Accession Number:: 0001209191-10-038106
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-07-12 13:00:00
Reporting Period:: 2010-07-09

Filing Date:: 2010-07-12
Accepted Time:: 2010-07-12 15:23:13
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1390478	Rxi Pharmaceuticals Corp	RXII	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1303479	D Noah Beerman	C/O Rxi Pharmaceuticals Corporation 60 Prescott Street Worcester MA 01605	Ceo And President	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-07-09	10,000	$2.23	15,407	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The purchase price reported in this Form 4 was between the range of $2.229 per share and $2.23 per share. Full information regarding the number of shares purchased at each seperate price will be provided to the Commission staff upon request.